tiprankstipranks
Trending News
More News >
IO Biotech (IOBT)
NASDAQ:IOBT
US Market

IO Biotech (IOBT) Financial Statements

Compare
450 Followers

IO Biotech Financial Overview

IO Biotech's market cap is currently $36.13M. The company's EPS TTM is $-0.13; its P/E ratio is -0.37; IO Biotech is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -849.00K$ -756.00K$ -540.00K$ 0.00$ 0.00
Operating Income$ -95.18M$ -91.44M$ -71.42M$ -41.23M$ -10.14M
EBITDA$ -93.20M$ -84.47M$ -69.34M$ -67.45M$ -12.02M
Net Income$ -95.49M$ -86.08M$ -71.46M$ -67.88M$ -12.04M
Balance Sheet
Cash & Short-Term Investments$ 60.03M$ 143.19M$ 142.59M$ 211.53M$ 3.40M
Total Assets$ 67.70M$ 150.72M$ 151.81M$ 222.29M$ 5.65M
Total Debt$ 1.92M$ 2.49M$ 2.79M$ 0.00$ 0.00
Net Debt$ -58.12M$ -140.70M$ -139.80M$ -211.53M$ -3.40M
Total Liabilities$ 20.68M$ 17.56M$ 12.95M$ 10.36M$ 3.05M
Stockholders' Equity$ 47.02M$ 133.16M$ 138.85M$ 211.92M$ 2.60M
Cash Flow
Free Cash Flow$ -82.39M$ -72.06M$ -60.42M$ -40.80M$ -9.96M
Operating Cash Flow$ -82.35M$ -71.74M$ -59.73M$ -40.65M$ -9.96M
Investing Cash Flow$ -44.00K$ -323.00K$ -690.00K$ -153.00K$ 0.00
Financing Cash Flow$ 0.00$ 71.86M$ 0.00$ 252.95M$ 5.10M
Currency in USD

IO Biotech Earnings and Revenue History

IO Biotech Debt to Assets

IO Biotech Cash Flow

IO Biotech Forecast EPS vs Actual EPS